Antiviral Dosing for Herpes Zoster in Immunocompetent Adults
For immunocompetent adults with herpes zoster, use acyclovir 800 mg orally five times daily for 7 days, valacyclovir 1000 mg orally three times daily for 7 days, or famciclovir 500 mg orally three times daily for 7 days.
Recommended Dosing Regimens
The evidence supports three equivalent first-line options for treating herpes zoster in immunocompetent adults:
Acyclovir
- 800 mg orally five times daily for 7 days 1, 2
- This is the most extensively studied regimen
- Must be initiated within 72 hours of rash onset for maximum benefit 3
- The 800 mg dose is significantly more effective than lower doses (200 mg) for shortening blister stopping time, pain duration, and scabbing time 4
Valacyclovir
- 1000 mg orally three times daily for 7 days 1, 2, 5
- Equivalent efficacy to famciclovir 5
- Better patient compliance than acyclovir due to less frequent dosing
- The 900-1000 mg three times daily regimen is superior to 300 mg twice daily, reducing postherpetic neuralgia incidence without increasing adverse effects 4
- A 1.5 g twice daily regimen has also shown comparable safety and efficacy 6
Famciclovir
- 500 mg orally three times daily for 7 days 1, 2, 5
- Comparable efficacy to valacyclovir 5
- Studies show 250 mg, 500 mg, and 750 mg three times daily have similar efficacy, making 250 mg a reasonable alternative 4, 7
Critical Timing Considerations
Treatment must begin within 72 hours of rash onset to achieve meaningful clinical benefit 3. Starting therapy after 48-72 hours shows no significant acceleration of rash healing 3. The window of therapeutic opportunity is brief, making early recognition and prompt treatment essential.
Treatment Goals and Expected Outcomes
Antiviral therapy achieves:
- Faster resolution of acute pain during treatment
- Reduced time to last new lesion formation
- Accelerated loss of vesicles and full crusting
- Shortened duration of zoster-associated pain
Important caveat: While antivirals reduce acute symptoms, the evidence for preventing postherpetic neuralgia is mixed. Some studies show benefit with higher doses of valacyclovir 4, while others show no significant effect on postherpetic neuralgia frequency or severity 3.
Practical Prescribing Algorithm
- Confirm diagnosis within 72 hours of rash onset
- Choose based on convenience and cost:
- Valacyclovir or famciclovir: Better compliance (3 times daily vs 5 times daily)
- Acyclovir: Lower cost but requires 5 daily doses
- Prescribe for 7 days regardless of agent chosen
- Adjust for renal impairment if creatinine clearance is reduced 2
Common Pitfalls to Avoid
- Do not use lower doses: 200 mg acyclovir or 300 mg valacyclovir twice daily are inadequate 4
- Do not delay treatment: Waiting beyond 72 hours eliminates therapeutic benefit 3
- Do not use topical antivirals alone: They are ineffective for herpes zoster 1, 2
- Do not confuse with HSV dosing: The provided evidence about genital herpes (HSV) dosing 8, 9, 8 is not applicable to herpes zoster (VZV)
Safety Profile
All three agents demonstrate similar, favorable safety profiles 5. The most common adverse events are headache and nausea, which are generally mild and self-limited 5. No clinically important adverse effects were reported in major trials 3.